CRISPR Therapeutics AG (CRSP)
56.89
+0.71
(+1.26%)
USD |
NASDAQ |
Jan 14, 16:00
57.44
+0.55
(+0.97%)
After-Hours: 05:00
CRISPR Therapeutics Market Cap: 5.422B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 114.05B |
| Intellia Therapeutics, Inc. | 1.392B |
| Beam Therapeutics, Inc. | 3.593B |
| Novartis AG | 280.45B |
| BeOne Medicines Ltd. | 38.37B |
Market Cap Related Metrics
| PS Ratio | 129.76 |
| PEG Ratio | -0.1044 |
| Price to Book Value | 2.830 |
| Price | 56.89 |
| Earnings Yield | -9.81% |
| PEGY Ratio | -0.1044 |